Lithium Controlled-Release and Extended-Release Tablets and Safinamide Mesylate
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Safinamide Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: safinamide
Brand name: Xadago
Synonyms: Safinamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Safyral
- Lithium Controlled-Release and Extended-Release Tablets-Saizen
- Lithium Controlled-Release and Extended-Release Tablets-Saizen Subcutaneous, Injection
- Lithium Controlled-Release and Extended-Release Tablets-Sal-Acid Plaster Topical
- Lithium Controlled-Release and Extended-Release Tablets-Sal-Plant
- Lithium Controlled-Release and Extended-Release Tablets-Sal-Plant Gel Topical
- Safinamide Mesylate-Lithium ER
- Safinamide Mesylate-Lithium Oral Solution
- Safinamide Mesylate-Lithium Salts
- Safinamide Mesylate-Lithium Syrup and Oral Solution
- Safinamide Mesylate-Lithobid
- Safinamide Mesylate-Lithostat